Command Palette

Search for a command to run...

JUBLPHARMA
1099(-2.24%)
1W: +4.15%

Jubilant Pharmova Key Ratios

Cash Conversion Cycle

Latest:-40.0 days

Return on Equity

Latest:14.3%

Return on Capital Employed

Latest:13.9%

Dupont Analysis

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
ROE13.02%11.09%8.21%-1.21%1.34%14.35%
PAT margin11.60%1.15%-0.97%6.75%13.71%15.03%
Asset Turnover0.51x0.58x0.66x0.61x0.60x0.61x
Leverage2.27x2.04x1.85x1.94x2.06x2.04x

Efficiency Ratios

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Inventory Days99.689.071.076.672.761.0
Receivable Days78.363.252.054.951.145.6
Payable Days264.7191.4133.5135.0143.0146.6
Cash Conversion Cycle-86.7-39.1-10.5-3.5-19.2-40.0

Return Ratios

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
ROE13.02%11.09%8.21%-1.21%1.34%14.35%
ROCE12.20%12.02%9.97%2.53%5.02%13.92%
ROA5.74%5.45%4.44%-0.63%0.65%7.02%

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.